Join to View Full Profile
865 Northern BoulevardSuite 302Great Neck, NY 11021
Phone+1 516-708-2550
Fax+1 516-708-2597
Dr. Furie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 1982 - 1984- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1979 - 1982
Weill Cornell MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1980 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Newsday - Top Doctors on Long Island Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
- Join now to see all
Publications & Presentations
PubMed
- Pharmacodynamic Effects of Litifilimab in Lupus in the LILAC Phase II Study: Rapid and Sustained Reductions in Type I Interferon-Associated Gene Expression and Cytokines.Richard Furie, Victoria P Werth, Eric Milliman, Kyle Ferber, Roland Brown
Arthritis & Rheumatology. 2025-06-09 - Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents.Anca D Askanase, Richard Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting
Rheumatology and Therapy. 2025-06-01 - Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.Kathryn Connelly, Rachel Koelmeyer, Darshini Ayton, John May, Kate Gregory
Lupus Science & Medicine. 2025-05-06
Journal Articles
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisRichard Furie, Brad H Rovin, The New England Journal of Medicine
Lectures
- 6th Annual Perspectives in Rheumatic DiseasesGlobal Academy for Medical Education (Elsevier), Las Vegas, Nevada - 9/20/2013
- Advances in B Cell Biology: Rheumatoid Arthritis, Systemic Lupus Erythematosus, & VasculitisCleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Scottsdale, Arizona - 2/18/2012
Press Mentions
Efgartigimod Use Extends to Myositis and Sjögren Disease in Phase 2 TrialsJune 30th, 2025- New Data at EULAR Signal Advances in RA, Myopathy, GoutJune 27th, 2025
- Feinstein Institutes Researchers Demonstrate Benefit to Patients with Lupus-Related Kidney DiseaseApril 17th, 2025
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
